Literature DB >> 35040910

Interpreting Geroscience-Guided Biomarker Studies.

Scott R Bauer1,2,3, John C Newman1,2,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35040910      PMCID: PMC8901559          DOI: 10.1001/jamainternmed.2021.7812

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

Review 1.  Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither?

Authors:  Jason L Sanders; Anne B Newman
Journal:  Epidemiol Rev       Date:  2013-01-09       Impact factor: 6.222

2.  Moving geroscience from the bench to clinical care and health policy.

Authors:  Felipe Sierra; Avshalom Caspi; Richard H Fortinsky; Laura Haynes; Gordon J Lithgow; Terrie E Moffitt; S Jay Olshansky; Daniel Perry; Eric Verdin; George A Kuchel
Journal:  J Am Geriatr Soc       Date:  2021-06-19       Impact factor: 5.562

Review 3.  A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup.

Authors:  Jamie N Justice; Luigi Ferrucci; Anne B Newman; Vanita R Aroda; Judy L Bahnson; Jasmin Divers; Mark A Espeland; Santica Marcovina; Michael N Pollak; Stephen B Kritchevsky; Nir Barzilai; George A Kuchel
Journal:  Geroscience       Date:  2018-08-27       Impact factor: 7.713

Review 4.  Syndromes of telomere shortening.

Authors:  Mary Armanios
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

Review 5.  From discoveries in ageing research to therapeutics for healthy ageing.

Authors:  Judith Campisi; Pankaj Kapahi; Gordon J Lithgow; Simon Melov; John C Newman; Eric Verdin
Journal:  Nature       Date:  2019-07-10       Impact factor: 49.962

Review 6.  The hallmarks of aging.

Authors:  Carlos López-Otín; Maria A Blasco; Linda Partridge; Manuel Serrano; Guido Kroemer
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.